Ana Luisa Figueira Gouvêa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana Luisa Figueira Gouvêa has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Jorge Reis Almeida
Universidade Federal Fluminense
5 shared publications - Jocemir Ronaldo Lugon
Universidade Federal Fluminense, Niterói, RJ, Brazil
4 shared publications - Camila de Melo Carvalho Nascimento
Postgraduate Program in Medical Sciences, Faculty of Medicine, Universidade Federal Fluminense, Niterói, Brazil
3 shared publications - Fabiana Rabe Carvalho
Universidade Federal Fluminense, Brazil
3 shared publications - Rachel Ingrid Juliboni Cosendey
Universidade Estácio de Sá
3 shared publications - Ana Lucia Rosa Nascimento
Universidade Estadual do Rio de Janeiro
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Tratando o outrora intratável: uma análise clínico-patológica de reversão da síndrome nefrótica secundária à amiloidose renal associada à gamopatia monoclonal
RESUMO A amiloidose constitui um grupo de distúrbios causados por erros no dobramento de proteínas e pela deposição extracelular de fibrilas insolúveis. A amiloidose de cadeia leve (AL) é a forma mais comum de amiloidose sistêmica, e o envolvimento renal frequentemente se manifesta como síndrome nefrótica. No entanto, o diagnóstico pode ser desafiador quando investigações hematológicas convencionais não conseguem demonstrar proteínas monoclonais. Relatamos o caso de um homem de 57 anos que desenvolveu edema progressivo, síndrome nefrótica e redução da função renal. A biópsia renal demonstrou depósitos de amiloide positivos ao vermelho Congo com restrição da cadeia leve lambda; porém, a eletroforese sérica, a imunofixação e as análises de cadeia leve sérica repetidas foram inconclusivas. O diagnóstico definitivo foi estabelecido somente após a espectrometria de massa identificar deposição de amiloide de cadeia leve lambda no tecido renal. O paciente foi tratado com daratumumabe, bortezomibe, ciclofosfamida e dexametasona (D-VCd), com melhora clínica e laboratorial significativa. No acompanhamento mais recente, ele permanece assintomático, sem edema, com níveis normais de albumina sérica, ausência de proteinúria e função renal preservada. Este caso destaca a complexidade diagnóstica da amiloidose AL em pacientes com estudos hematológicos inconclusivos e enfatiza como novas opções terapêuticas podem melhorar dramaticamente o prognóstico da doença.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Open AccessTratando o outrora intratável: uma análise clínico-patológica de reversão da síndrome nefrótica secundária à amiloidose renal associada à gamopatia monoclonal
RESUMO A amiloidose constitui um grupo de distúrbios causados por erros no dobramento de proteínas e pela deposição extracelular de fibrilas insolúveis. A amiloidose de cadeia leve (AL) é a forma mais comum de amiloidose sistêmica, e o envolvimento renal frequentemente se manifesta como síndrome nefrótica. No entanto, o diagnóstico pode ser desafiador quando investigações hematológicas convencionais não conseguem demonstrar proteínas monoclonais. Relatamos o caso de um homem de 57 anos que desenvolveu edema progressivo, síndrome nefrótica e redução da função renal. A biópsia renal demonstrou depósitos de amiloide positivos ao vermelho Congo com restrição da cadeia leve lambda; porém, a eletroforese sérica, a imunofixação e as análises de cadeia leve sérica repetidas foram inconclusivas. O diagnóstico definitivo foi estabelecido somente após a espectrometria de massa identificar deposição de amiloide de cadeia leve lambda no tecido renal. O paciente foi tratado com daratumumabe, bortezomibe, ciclofosfamida e dexametasona (D-VCd), com melhora clínica e laboratorial significativa. No acompanhamento mais recente, ele permanece assintomático, sem edema, com níveis normais de albumina sérica, ausência de proteinúria e função renal preservada. Este caso destaca a complexidade diagnóstica da amiloidose AL em pacientes com estudos hematológicos inconclusivos e enfatiza como novas opções terapêuticas podem melhorar dramaticamente o prognóstico da doença.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
A clinicopathologic analysis of reversal of nephrotic syndrome secondary to renal amyloidosis associated with monoclonal gammopathy
Amyloidosis is a group of disorders caused by protein misfolding and extracellular deposition of insoluble fibrils. Light chain amyloidosis (AL) is the most common form of systemic amyloidosis, and kidney involvement frequently manifests as nephrotic syndrome. However, diagnosis may be challenging when conventional hematologic investigations fail to demonstrate monoclonal proteins. We report the case of a 57-year-old man who developed progressive edema, nephrotic syndrome, and reduced kidney function. Kidney biopsy demonstrated Congo red-positive amyloid deposits with lambda light chain restriction, but repeated serum electrophoresis, immunofixation, and serum free light chain studies were inconclusive. The definitive diagnosis was established only after mass spectrometry identified lambda light chain amyloid deposition. The patient was treated with daratumumab, bortezomib, cyclophosphamide, and dexamethasone (D-VCd), with marked clinical and laboratory improvement. At the latest follow-up, he remained asymptomatic, without edema, with normal serum albumin levels, absence of proteinuria, and preserved kidney function. This case highlights the diagnostic complexity of AL amyloidosis in patients with inconclusive hematologic studies and emphasizes how newer therapeutic options can dramatically improve the prognosis of this disease.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Open AccessA clinicopathologic analysis of reversal of nephrotic syndrome secondary to renal amyloidosis associated with monoclonal gammopathy
Amyloidosis is a group of disorders caused by protein misfolding and extracellular deposition of insoluble fibrils. Light chain amyloidosis (AL) is the most common form of systemic amyloidosis, and kidney involvement frequently manifests as nephrotic syndrome. However, diagnosis may be challenging when conventional hematologic investigations fail to demonstrate monoclonal proteins. We report the case of a 57-year-old man who developed progressive edema, nephrotic syndrome, and reduced kidney function. Kidney biopsy demonstrated Congo red-positive amyloid deposits with lambda light chain restriction, but repeated serum electrophoresis, immunofixation, and serum free light chain studies were inconclusive. The definitive diagnosis was established only after mass spectrometry identified lambda light chain amyloid deposition. The patient was treated with daratumumab, bortezomib, cyclophosphamide, and dexamethasone (D-VCd), with marked clinical and laboratory improvement. At the latest follow-up, he remained asymptomatic, without edema, with normal serum albumin levels, absence of proteinuria, and preserved kidney function. This case highlights the diagnostic complexity of AL amyloidosis in patients with inconclusive hematologic studies and emphasizes how newer therapeutic options can dramatically improve the prognosis of this disease.
- Open Access
- 8 December 2023
- Published by Universidade Alto Vale Do Rio Do Peixe - Uniarp in Revista Interdisciplinar de Estudos em Saúde
- Vol. 1 (1) , 133-146
THE ASSESSMENT OF DNA DAMAGE BY ALKALINE COMET ASSAY IS NOT ASSOCIATED WITH CLINICAL OUTCOMES IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Introduction: In systemic lupus erythematosus (SLE), an inflammatory state leads to oxidative stress and excessive formation of reactive oxygen species, increasing cellular damage, mutations and compromised DNA repair. Therefore, our study aimed to evaluate the performance of the alkaline comet assay to investigate DNA damage in women with SLE.Methods: This is a cross-sectional study that included Brazilian women with SLE attended at an university hospital (Rio de Janeiro, Brazil) from 2015 to 2018. Disease activity was assessed using the SLE Disease Activity Index 2000 (SLEDAI-2K). Diagnosis of CMVand EBV infections were performed by qPCR. DNA damage was determined by alkaline comet assay, which is a electrophoresis techinique used to evaluate DNA fragmentation in leukocytes, which is expressed as arbitrary units (AU). Results: We studied 34 SLE patients with a median age of 34.5 years-old. Hospitalized patients (n=11, 32.3%) presented higher SLEDAI-2K, where 9 (81.8%) had SLEDAI-2K ≥ 5 (p=0.038). We did not identify significant differences between healthy and SLE; however, hospitalized patients showed higher median AU, but with no statistical significance (p=0.095). Also, no differences were in DNA damage according to SLEDAI-2, lupus nephritis, use of immunossupressants, or CMV/EBV infections. DNA damage was not associated with levels of anti-dsDNA. Lastlty, ROC curves demonstrated a poor predictive power of DNA damage to differentiate groups (AUC < 0.7, p > 0,05). Conclusion: Our results indicate that DNA damage measured by alkaline comet assay is not associated with SLE severity and the presence of viral infections
- 8 December 2023
- Published by Universidade Alto Vale Do Rio Do Peixe - Uniarp in Revista Interdisciplinar de Estudos em Saúde
- Vol. 1 (1) , 133-146
Open AccessTHE ASSESSMENT OF DNA DAMAGE BY ALKALINE COMET ASSAY IS NOT ASSOCIATED WITH CLINICAL OUTCOMES IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Introduction: In systemic lupus erythematosus (SLE), an inflammatory state leads to oxidative stress and excessive formation of reactive oxygen species, increasing cellular damage, mutations and compromised DNA repair. Therefore, our study aimed to evaluate the performance of the alkaline comet assay to investigate DNA damage in women with SLE.Methods: This is a cross-sectional study that included Brazilian women with SLE attended at an university hospital (Rio de Janeiro, Brazil) from 2015 to 2018. Disease activity was assessed using the SLE Disease Activity Index 2000 (SLEDAI-2K). Diagnosis of CMVand EBV infections were performed by qPCR. DNA damage was determined by alkaline comet assay, which is a electrophoresis techinique used to evaluate DNA fragmentation in leukocytes, which is expressed as arbitrary units (AU). Results: We studied 34 SLE patients with a median age of 34.5 years-old. Hospitalized patients (n=11, 32.3%) presented higher SLEDAI-2K, where 9 (81.8%) had SLEDAI-2K ≥ 5 (p=0.038). We did not identify significant differences between healthy and SLE; however, hospitalized patients showed higher median AU, but with no statistical significance (p=0.095). Also, no differences were in DNA damage according to SLEDAI-2, lupus nephritis, use of immunossupressants, or CMV/EBV infections. DNA damage was not associated with levels of anti-dsDNA. Lastlty, ROC curves demonstrated a poor predictive power of DNA damage to differentiate groups (AUC < 0.7, p > 0,05). Conclusion: Our results indicate that DNA damage measured by alkaline comet assay is not associated with SLE severity and the presence of viral infections
- Open Access
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Existe Ainda um Papel para a Citologia Urinária no Transplante Renal? Relato de Experiência em um Hospital Universitário
Introdução: A citologia urinária tem sido utilizada como estratégia de monitoramento dos pacientes transplantados renais, que vivem sob crônica imunossupressão, por ser um método não invasivo e de baixo custo. A detecção precoce de infecções pode prevenir possíveis disfunções e perda do enxerto. No entanto, a sua utilização tem decrescido. Métodos: Realizamos um estudo prospectivo em amostras de urina provenientes de 29 pacientes consecutivos, submetidos ao transplante renal ao longo de um período contínuo de 17 meses, coletadas durante seu primeiro ano pós-transplante. Um mesmo técnico preparou as amostras por citocentrifugação, coloração de Papanicolaou e um único patologista as analisou. Amostras positivas para “decoy cells” (DCs) foram preparadas por dois outros técnicos, para análise por microscopia de contraste de fase, estudo ultraestrutural e imunofluorescência (antígeno T SV40). Resultados: Foram avaliadas 252 amostras de urina de 26 pacientes. Duas amostras consecutivas (0,8%) dentre cinco, de uma mesma paciente (3,8%), referentes à quarta e quinta semana pós-transplante, apresentaram lesão intraepitelial escamosa de baixo grau; na amostra referente ao sexto mês pós-transplante foram detectadas apenas raras células epiteliais com atipias de significado indeterminado (0,4%); o posterior exame ginecológico da paciente e teste de Papanicolaou não revelaram alterações. Pseudohifas e esporos fúngicos foram encontrados em cinco amostras (2,0%) de quatro pacientes (15,4%). Trichosporon sp. foi identificado na urina de um desses pacientes. Decoy cells foram detectadas em 25 amostras (9,9%) de seis pacientes (23,1%). Dois pacientes tiveram eliminação sustentada de DCs; um deles, apresentando esfregaço de fundo sujo, desenvolveu Nefropatia associada ao poliomavírus. O estudo ultraestrutural das DCs mostrou partículas virais icosaédricas. A imunofluorescência (antígeno T SV40) foi positiva nos núcleos das DCs. A análise por microscopia de contraste de fase foi bem-sucedida em amostras com numerosas DCs. Conclusão: A citologia urinária sistemática após o transplante é útil na detecção de alguns sinais de infecção. Pacientes com eliminação sustentada de DCs e esfregaços de fundo sujo merecem atenção clínica especial. A microscopia eletrônica e a imunofluorescência (antígeno T SV40) são técnicas alternativas para detectar a reativação do poliomavírus. Os resultados sugerem que a citologia urinária ainda desempenha um papel no transplante renal.
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Open AccessExiste Ainda um Papel para a Citologia Urinária no Transplante Renal? Relato de Experiência em um Hospital Universitário
Introdução: A citologia urinária tem sido utilizada como estratégia de monitoramento dos pacientes transplantados renais, que vivem sob crônica imunossupressão, por ser um método não invasivo e de baixo custo. A detecção precoce de infecções pode prevenir possíveis disfunções e perda do enxerto. No entanto, a sua utilização tem decrescido. Métodos: Realizamos um estudo prospectivo em amostras de urina provenientes de 29 pacientes consecutivos, submetidos ao transplante renal ao longo de um período contínuo de 17 meses, coletadas durante seu primeiro ano pós-transplante. Um mesmo técnico preparou as amostras por citocentrifugação, coloração de Papanicolaou e um único patologista as analisou. Amostras positivas para “decoy cells” (DCs) foram preparadas por dois outros técnicos, para análise por microscopia de contraste de fase, estudo ultraestrutural e imunofluorescência (antígeno T SV40). Resultados: Foram avaliadas 252 amostras de urina de 26 pacientes. Duas amostras consecutivas (0,8%) dentre cinco, de uma mesma paciente (3,8%), referentes à quarta e quinta semana pós-transplante, apresentaram lesão intraepitelial escamosa de baixo grau; na amostra referente ao sexto mês pós-transplante foram detectadas apenas raras células epiteliais com atipias de significado indeterminado (0,4%); o posterior exame ginecológico da paciente e teste de Papanicolaou não revelaram alterações. Pseudohifas e esporos fúngicos foram encontrados em cinco amostras (2,0%) de quatro pacientes (15,4%). Trichosporon sp. foi identificado na urina de um desses pacientes. Decoy cells foram detectadas em 25 amostras (9,9%) de seis pacientes (23,1%). Dois pacientes tiveram eliminação sustentada de DCs; um deles, apresentando esfregaço de fundo sujo, desenvolveu Nefropatia associada ao poliomavírus. O estudo ultraestrutural das DCs mostrou partículas virais icosaédricas. A imunofluorescência (antígeno T SV40) foi positiva nos núcleos das DCs. A análise por microscopia de contraste de fase foi bem-sucedida em amostras com numerosas DCs. Conclusão: A citologia urinária sistemática após o transplante é útil na detecção de alguns sinais de infecção. Pacientes com eliminação sustentada de DCs e esfregaços de fundo sujo merecem atenção clínica especial. A microscopia eletrônica e a imunofluorescência (antígeno T SV40) são técnicas alternativas para detectar a reativação do poliomavírus. Os resultados sugerem que a citologia urinária ainda desempenha um papel no transplante renal.
- Open Access
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Is There Still a Role for Urine Cytology in Kidney Transplantation? Experience Report in a Teaching Hospital
Introduction: Urinary cytology has been used as a monitoring strategy for kidney transplant patients, live under chronic immunosuppression, as it is a non-invasive and low-cost method. The early detection of infections can prevent possible dysfunction and graft loss. However, its use has been decreased. Methods: We conducted a prospective study on voided urine samples from 29 consecutive patients undergoing kidney transplantation over a continuous period of 17 months, collected during their first-year post-transplantation. One technician prepared the samples by cytocentrifugation, Papanicolaou staining, and one pathologist analyzed them. Decoy cells (DCs) positive samples were prepared, by other two technicians, for contrast phase analysis, ultrastructural study, and immunofluorescence for SV40 T antigen. Results: We evaluated 252 urine samples from 26 patients. Two consecutive samples (0.8%) out of five, from the same patient (3.8%), referring to the fourth- and fifth-week post-transplant, showed low-grade squamous intraepithelial lesions; only rare epithelial cells with atypia of undetermined significance were detected (0.4%) in the sample corresponding to the sixth month post-transplant. The patient’s subsequent gynecological examination and Pap smear revealed no changes. Pseudohyphae and fungus yeasts were found in five samples (2.0%) from four patients (15.4%). Trichosporon sp. was identified in the urine of one of these patients. Decoy cells were detected in 25 samples (9.9 %) from six patients (23.1%). Two patients had sustained DCs shedding; one of them, presenting dirty background smears, developed Polyomavirus-associated nephropathy. Ultrastructural study of DCs showed icosahedral viral particles. Immunofluorescence (SV40 T antigen) was positive in DCs nuclei. Analysis by contrast phase was successful in samples with numerous DCs. Conclusion: Systematic urinary cytology after transplantation helps detect some infection signs. Patients with sustained DCs shedding and dirty background smears deserve special clinical attention. Electron microscopy and immunofluorescence (SV40 T antigen) are alternative techniques to detect polyomavirus reactivation. The findings suggest that urinary cytology still plays a role in kidney transplantation.
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Open AccessIs There Still a Role for Urine Cytology in Kidney Transplantation? Experience Report in a Teaching Hospital
Introduction: Urinary cytology has been used as a monitoring strategy for kidney transplant patients, live under chronic immunosuppression, as it is a non-invasive and low-cost method. The early detection of infections can prevent possible dysfunction and graft loss. However, its use has been decreased. Methods: We conducted a prospective study on voided urine samples from 29 consecutive patients undergoing kidney transplantation over a continuous period of 17 months, collected during their first-year post-transplantation. One technician prepared the samples by cytocentrifugation, Papanicolaou staining, and one pathologist analyzed them. Decoy cells (DCs) positive samples were prepared, by other two technicians, for contrast phase analysis, ultrastructural study, and immunofluorescence for SV40 T antigen. Results: We evaluated 252 urine samples from 26 patients. Two consecutive samples (0.8%) out of five, from the same patient (3.8%), referring to the fourth- and fifth-week post-transplant, showed low-grade squamous intraepithelial lesions; only rare epithelial cells with atypia of undetermined significance were detected (0.4%) in the sample corresponding to the sixth month post-transplant. The patient’s subsequent gynecological examination and Pap smear revealed no changes. Pseudohyphae and fungus yeasts were found in five samples (2.0%) from four patients (15.4%). Trichosporon sp. was identified in the urine of one of these patients. Decoy cells were detected in 25 samples (9.9 %) from six patients (23.1%). Two patients had sustained DCs shedding; one of them, presenting dirty background smears, developed Polyomavirus-associated nephropathy. Ultrastructural study of DCs showed icosahedral viral particles. Immunofluorescence (SV40 T antigen) was positive in DCs nuclei. Analysis by contrast phase was successful in samples with numerous DCs. Conclusion: Systematic urinary cytology after transplantation helps detect some infection signs. Patients with sustained DCs shedding and dirty background smears deserve special clinical attention. Electron microscopy and immunofluorescence (SV40 T antigen) are alternative techniques to detect polyomavirus reactivation. The findings suggest that urinary cytology still plays a role in kidney transplantation.
- Open Access
- 1 December 2018
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 40 (4) , 423-427
Hemophagocytic lymphohistiocytosis, a rare condition in renal transplant - a case report
Hemophagocytic lymphohistiocytosis (HLH) is an uncommon and life-threating condition characterized by major immune activation and massive cytokine production by mononuclear inflammatory cells, due to defects in cytotoxic lymphocyte function. It is even more unusual in renal transplant recipients, in which it is often associated with uncontrolled infection. The mortality is high in HLH and differential diagnosis with sepsis is a challenge. The approach and management depend on the underlying trigger and comorbidities. We report a case of a 50-year-old renal transplant female admitted with fever and malaise 3 months post-transplant and presenting anemia, fever, hypertriglyceridemia, high levels of serum ferritin, and positive CMV antigenemia. Urine was positive for decoy cells and BKV-DNA. Graft biopsy showed CMV nephritis. Both blood and urine cultures where positive for E. coli. Hemophagocytosis was confirmed by bone marrow aspiration. Immunosuppression was reduced, and the patient received high-dose intravenous immunoglobulin and dexamethasone, with complete response after 3 weeks. We highlight the importance of early diagnosis and proper management of a rare and serious condition in a renal transplant patient, which can allow a favorable clinical course and improve survival rate.
- 1 December 2018
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 40 (4) , 423-427
Open AccessHemophagocytic lymphohistiocytosis, a rare condition in renal transplant - a case report
Hemophagocytic lymphohistiocytosis (HLH) is an uncommon and life-threating condition characterized by major immune activation and massive cytokine production by mononuclear inflammatory cells, due to defects in cytotoxic lymphocyte function. It is even more unusual in renal transplant recipients, in which it is often associated with uncontrolled infection. The mortality is high in HLH and differential diagnosis with sepsis is a challenge. The approach and management depend on the underlying trigger and comorbidities. We report a case of a 50-year-old renal transplant female admitted with fever and malaise 3 months post-transplant and presenting anemia, fever, hypertriglyceridemia, high levels of serum ferritin, and positive CMV antigenemia. Urine was positive for decoy cells and BKV-DNA. Graft biopsy showed CMV nephritis. Both blood and urine cultures where positive for E. coli. Hemophagocytosis was confirmed by bone marrow aspiration. Immunosuppression was reduced, and the patient received high-dose intravenous immunoglobulin and dexamethasone, with complete response after 3 weeks. We highlight the importance of early diagnosis and proper management of a rare and serious condition in a renal transplant patient, which can allow a favorable clinical course and improve survival rate.
- Open Access
- 24 May 2017
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 1-6
BK polyomavirus nephropathy in two kidney transplant patients with distinct diagnostic strategies for BK virus and similar clinical outcomes: two case reports
BK polyomavirus-associated nephropathy is an important cause of post-transplantation renal failure. We present two cases of BK polyomavirus-associated nephropathy who were submitted to contrasting strategies of clinical follow-up to BK polyomavirus reactivation, but progressed to a similar final outcome. Case 1 is a 37-year-old white man whose graft had never presented a good glomerular filtration rate function, with episodes of tacrolimus nephrotoxicity, and no urinary monitoring for BK polyomavirus; stage B BK polyomavirus-associated nephropathy was diagnosed by biopsy at 14 months post-transplant. Despite clinical treatment (dosage decrease and immunosuppressive drug change), he progressed to stage C BK polyomavirus-associated nephropathy and loss of graft function 30 months post-transplant. Case 2 is a 49-year-old mulatto man in his second renal transplantation who was submitted to cytological urinary monitoring for BK polyomavirus; he presented early, persistent, and massive urinary decoy cell shedding and concomitant tacrolimus nephrotoxicity. Even with decreasing immunosuppression, he developed BK polyomavirus-associated nephropathy 1-year post-transplant. Loss of graft function occurred 15 months post-transplant. Cytological urinary monitoring was an efficient strategy for monitoring BK virus reactivation. Decoy cell shedding may be related to BK polyomavirus-associated nephropathy when extensive and persistent. The presence of associated tacrolimus nephrotoxicity may be a confounding factor for the clinical diagnosis of BK polyomavirus-associated nephropathy.
- 24 May 2017
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 1-6
Open AccessBK polyomavirus nephropathy in two kidney transplant patients with distinct diagnostic strategies for BK virus and similar clinical outcomes: two case reports
BK polyomavirus-associated nephropathy is an important cause of post-transplantation renal failure. We present two cases of BK polyomavirus-associated nephropathy who were submitted to contrasting strategies of clinical follow-up to BK polyomavirus reactivation, but progressed to a similar final outcome. Case 1 is a 37-year-old white man whose graft had never presented a good glomerular filtration rate function, with episodes of tacrolimus nephrotoxicity, and no urinary monitoring for BK polyomavirus; stage B BK polyomavirus-associated nephropathy was diagnosed by biopsy at 14 months post-transplant. Despite clinical treatment (dosage decrease and immunosuppressive drug change), he progressed to stage C BK polyomavirus-associated nephropathy and loss of graft function 30 months post-transplant. Case 2 is a 49-year-old mulatto man in his second renal transplantation who was submitted to cytological urinary monitoring for BK polyomavirus; he presented early, persistent, and massive urinary decoy cell shedding and concomitant tacrolimus nephrotoxicity. Even with decreasing immunosuppression, he developed BK polyomavirus-associated nephropathy 1-year post-transplant. Loss of graft function occurred 15 months post-transplant. Cytological urinary monitoring was an efficient strategy for monitoring BK virus reactivation. Decoy cell shedding may be related to BK polyomavirus-associated nephropathy when extensive and persistent. The presence of associated tacrolimus nephrotoxicity may be a confounding factor for the clinical diagnosis of BK polyomavirus-associated nephropathy.